Shao Xiang
Associate Profe
Applied Economi
Add: Guoshun Road Siyuan Building Room 332, Siyuan Building
Tel: 25011080(TEL)
E-mail: xshao@fudan.edu.cn
Research Field: International Economics, Corporate Finance
Website: https://xiangshao.github.io/
Educational Background
Doctor Degree,International Business & Strategy,The University of Hong Kong, HK
Bachelor Degree,International Business & Trade,Fudan University
Academic Background
2020.02——2020.06,Visiting Scholar,MIT Sloan School of Management, USA
Awards on Research
2018.07,Excellent Paper Award, The second Chinese economics development forum,The second Chinese economics development forum
Journal Papers
| 1. | Xuchao Li, Xiang Shao, Guangjun Shen, and Jingxian Zou. 2025. Bank competition and formation of zombie firms: Evidence from banking deregulation in China. Journal of Banking & Finance 172 1-14.  |
| 2. | Ji Huang, Zongbo Huang, and Xiang Shao. 2023. The risk of implicit guarantees: Evidence from shadow banks in China. Review of Finance 27(4) 1521–1544. |
| 3. | Tao Chen, Chen Lin, and Xiang Shao. 2022. Globalization and U.S. corporate tax policies: Evidence from import competition. Management Science 68(8) 6145-6162. |
| 4. | Yue Li, Xiang Shao, Zhigang Tao, and Hongjie Yuan. 2022. How local leaders matter: Inter-provincial leadership transfers and land transactions in China. Journal of Comparative Economics 50(1) 196-220. |
| 5. | Mengna Luan, Xiang Shao, and Fengman Dou. 2020. Financial conditions, health care provision, and patient outcomes: Evidence from Chinese public hospitals. Economics Letters 186 1-4. |
| 6. | Wen Cao, Qinyang Sha, Zhiyong Yao, Dingwei Gu, and Xiang Shao. 2019. Sniping in soft-close online auctions: Empirical evidence from overstock. Marketing Letters 30(2) 179–191. |
| 7. | Yi Lu, Xiang Shao, and Zhigang Tao. 2018. Exposure to Chinese imports and media slant: Evidence from 147 U.S. local newspapers over 1998-2012. Journal of International Economics 114 316-330. |
Research Projects
2024.06—2025.05, Principal Investigator, Internationalization Strategy of Chinese Pharmatheutical Companies in Emerging Markets, Shanghai Municipal Science and Technology Committee
2024.01—2026.12, Principal Investigator, R&D Information Disclosure and R&D Competition: Research Based on Clinical Trial Disclosure Strategy of Pharmaceutical Companies, National Natural Science Foundation of China
2022.03—2023.02, Principal Investigator, Research on Hospital Procurement and Development in Pharmaceutical Industry in Shanghai, Shanghai Municipal Commission of Science and Technology
2022.01—2026.12, Member, Research on Scientific Antitrust Regulation in the Digital Economy, The Key Project of National Natural Science Foundation of China
2019.09—2019.12, Principal Investigator, Guangxi's Integration into the Industrial Development of Greater Bay Area, Program of Fudan Development Institute
2019.03—2019.12, Principal Investigator, American Global Strategy in Trump's Era, Fudan Development Institute Sino-US Mutual Trust and Cooperation Program
2019.03—2022.02, Principal Investigator, Lobbying Activities and U.S-China Trade Relationship, The University of Hong Kong- Fudan University IMBA Joint Research Fund
2019.01—2020.12, Co-PI, Credit Supply and Healthcare Service Quality , Hong Kong Research Grants Council, General Research Fund
2018.12—2019.03, Principal Investigator, Research on How to Promote Trade Facilitation and Reduce Bad Loan Rate, Fudan Development Institute
Academic Posts
2022.09—,Associate Editor,Journal of Asian Economics
2022.01—,Fellow Member,China Society for World Economics
Case
Xiang Shao，Lingfang Li，Paizhuo Li，Jieyou Zhang, Xinbang：Informatization Leads to Management Reform, , 2023
- firstpage <<previouspage nextpage>> endpage
- PageNumber 1/3
